Published in Adv Healthc Mater on June 24, 2014
Synthesis, properties, and biomedical applications of gelatin methacryloyl (GelMA) hydrogels. Biomaterials (2015) 1.15
Simulation of early calcific aortic valve disease in a 3D platform: A role for myofibroblast differentiation. J Mol Cell Cardiol (2016) 0.78
Engineering approaches to study fibrosis in 3-D in vitro systems. Curr Opin Biotechnol (2016) 0.76
Inflammation Drives Retraction, Stiffening, and Nodule Formation via Cytoskeletal Machinery in a Three-Dimensional Culture Model of Aortic Stenosis. Am J Pathol (2016) 0.76
Robust Generation of Quiescent Porcine Valvular Interstitial Cell Cultures. J Am Heart Assoc (2017) 0.75
Advances in the treatment of aortic valve disease: is it time for companion diagnostics? Curr Opin Pediatr (2014) 0.75
Engineered 3D Cardiac Fibrotic Tissue to Study Fibrotic Remodeling. Adv Healthc Mater (2017) 0.75
Current Challenges in Translating Tissue-Engineered Heart Valves. Curr Treat Options Cardiovasc Med (2017) 0.75
Tissue cells feel and respond to the stiffness of their substrate. Science (2005) 23.42
Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol (2002) 14.80
Extracellular matrix rigidity causes strengthening of integrin-cytoskeleton linkages. Cell (1997) 10.22
Bone formation and inflammation in cardiac valves. Circulation (2001) 6.01
Cellular mechanotransduction: putting all the pieces together again. FASEB J (2006) 5.84
Alpha-smooth muscle actin expression upregulates fibroblast contractile activity. Mol Biol Cell (2001) 4.25
Hydrogels in regenerative medicine. Adv Mater (2009) 3.80
Cell-laden microengineered gelatin methacrylate hydrogels. Biomaterials (2010) 3.72
Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease. Circulation (2007) 3.51
Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves. Circulation (2001) 3.47
Focal adhesion kinase is involved in mechanosensing during fibroblast migration. Proc Natl Acad Sci U S A (2001) 3.41
Valvular myofibroblast activation by transforming growth factor-beta: implications for pathological extracellular matrix remodeling in heart valve disease. Circ Res (2004) 2.45
In situ elasticity modulation with dynamic substrates to direct cell phenotype. Biomaterials (2009) 2.41
Arterial and aortic valve calcification abolished by elastolytic cathepsin S deficiency in chronic renal disease. Circulation (2009) 2.07
Evolving concepts of cardiac valve dynamics: the continuum of development, functional structure, pathobiology, and tissue engineering. Circulation (2008) 1.99
Injectable hydrogel properties influence infarct expansion and extent of postinfarction left ventricular remodeling in an ovine model. Proc Natl Acad Sci U S A (2010) 1.87
Spatial heterogeneity of endothelial phenotypes correlates with side-specific vulnerability to calcification in normal porcine aortic valves. Circ Res (2005) 1.80
Characterization of valvular interstitial cell function in three dimensional matrix metalloproteinase degradable PEG hydrogels. Biomaterials (2009) 1.77
Photocrosslinking of gelatin macromers to synthesize porous hydrogels that promote valvular interstitial cell function. Tissue Eng Part A (2009) 1.67
Atorvastatin inhibits calcification and enhances nitric oxide synthase production in the hypercholesterolaemic aortic valve. Heart (2005) 1.65
Cell-matrix interactions in the pathobiology of calcific aortic valve disease: critical roles for matricellular, matricrine, and matrix mechanics cues. Circ Res (2011) 1.61
Crosslinked hyaluronan scaffolds as a biologically active carrier for valvular interstitial cells. Biomaterials (2005) 1.51
Synergistic effects of cyclic tension and transforming growth factor-beta1 on the aortic valve myofibroblast. Cardiovasc Pathol (2007) 1.41
Calcific aortic stenosis--time to look more closely at the valve. N Engl J Med (2008) 1.41
The effect of bioactive hydrogels on the secretion of extracellular matrix molecules by valvular interstitial cells. Biomaterials (2008) 1.07
Investigating the role of substrate stiffness in the persistence of valvular interstitial cell activation. J Biomed Mater Res A (2012) 1.04
Stiffness and adhesivity control aortic valve interstitial cell behavior within hyaluronic acid based hydrogels. Acta Biomater (2013) 1.02
Human cardiac valve interstitial cells in collagen sponge: a biological three-dimensional matrix for tissue engineering. J Heart Valve Dis (2002) 1.02
Regulation of valvular interstitial cell phenotype and function by hyaluronic acid in 2-D and 3-D culture environments. Matrix Biol (2010) 1.01
Serotonin receptors and heart valve disease--it was meant 2B. Pharmacol Ther (2011) 0.99
Correlates and causes of death in patients with severe symptomatic aortic stenosis who are not eligible to participate in a clinical trial of transcatheter aortic valve implantation. Circulation (2010) 0.98
Measurement of layer-specific mechanical properties in multilayered biomaterials by micropipette aspiration. Acta Biomater (2010) 0.97
Hyaluronan concentration within a 3D collagen matrix modulates matrix viscoelasticity, but not fibroblast response. Matrix Biol (2009) 0.96
Synthesis and characterization of hybrid hyaluronic acid-gelatin hydrogels. Biomacromolecules (2013) 0.96
Comparison of biomechanical and structural properties between human aortic and pulmonary valve. Eur J Cardiothorac Surg (2004) 0.94
The elastic properties of valve interstitial cells undergoing pathological differentiation. J Biomech (2011) 0.93
Inhibition of pathological differentiation of valvular interstitial cells by C-type natriuretic peptide. Arterioscler Thromb Vasc Biol (2011) 0.91
Surface-modified hyaluronic acid hydrogels to capture endothelial progenitor cells. Soft Matter (2010) 0.90
Designing biomaterials to direct stem cell fate. ACS Nano (2012) 0.85
The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med (2007) 11.51
Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science (2009) 10.47
Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J Clin Invest (2007) 8.65
Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib. Lancet (2007) 6.76
Transcriptional coactivator PGC-1 alpha controls the energy state and contractile function of cardiac muscle. Cell Metab (2005) 4.65
Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells. Cancer Res (2004) 4.56
Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc Natl Acad Sci U S A (2004) 4.13
Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis. Circulation (2007) 3.85
Hydrogels in regenerative medicine. Adv Mater (2009) 3.80
Cell-laden microengineered gelatin methacrylate hydrogels. Biomaterials (2010) 3.72
Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis. Circulation (2006) 3.57
Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease. Proc Natl Acad Sci U S A (2006) 3.38
Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation. PLoS Biol (2012) 3.18
Directed assembly of cell-laden microgels for fabrication of 3D tissue constructs. Proc Natl Acad Sci U S A (2008) 3.17
Left bundle-branch block induced by transcatheter aortic valve implantation increases risk of death. Circulation (2012) 2.95
Impaired infarct healing in atherosclerotic mice with Ly-6C(hi) monocytosis. J Am Coll Cardiol (2010) 2.90
Dual channel optical tomographic imaging of leukocyte recruitment and protease activity in the healing myocardial infarct. Circ Res (2007) 2.77
Human semilunar cardiac valve remodeling by activated cells from fetus to adult: implications for postnatal adaptation, pathology, and tissue engineering. Circulation (2006) 2.68
Microwell-mediated control of embryoid body size regulates embryonic stem cell fate via differential expression of WNT5a and WNT11. Proc Natl Acad Sci U S A (2009) 2.56
Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo. Circulation (2006) 2.56
Engineering complex tissues. Tissue Eng (2006) 2.53
Real-time catheter molecular sensing of inflammation in proteolytically active atherosclerosis. Circulation (2008) 2.52
Controlling size, shape and homogeneity of embryoid bodies using poly(ethylene glycol) microwells. Lab Chip (2007) 2.30
Carbon-nanotube-embedded hydrogel sheets for engineering cardiac constructs and bioactuators. ACS Nano (2013) 2.23
Optical visualization of cathepsin K activity in atherosclerosis with a novel, protease-activatable fluorescence sensor. Circulation (2007) 2.20
Fluorescence tomography and magnetic resonance imaging of myocardial macrophage infiltration in infarcted myocardium in vivo. Circulation (2007) 2.19
18F-4V for PET-CT imaging of VCAM-1 expression in atherosclerosis. JACC Cardiovasc Imaging (2009) 2.17
Hybrid in vivo FMT-CT imaging of protease activity in atherosclerosis with customized nanosensors. Arterioscler Thromb Vasc Biol (2009) 2.15
A cell-laden microfluidic hydrogel. Lab Chip (2007) 2.15
Micromolding of shape-controlled, harvestable cell-laden hydrogels. Biomaterials (2006) 2.12
Diffusion spectrum MRI tractography reveals the presence of a complex network of residual myofibers in infarcted myocardium. Circ Cardiovasc Imaging (2009) 2.12
A microwell array system for stem cell culture. Biomaterials (2007) 2.10
Automated 3D analysis of pre-procedural MDCT to predict annulus plane angulation and C-arm positioning: benefit on procedural outcome in patients referred for TAVR. JACC Cardiovasc Imaging (2013) 2.10
Active adaptation of the tethered mitral valve: insights into a compensatory mechanism for functional mitral regurgitation. Circulation (2009) 2.08
Characterization of human atherosclerotic plaques by intravascular magnetic resonance imaging. Circulation (2005) 2.05
Dynamic and reversible changes of interstitial cell phenotype during remodeling of cardiac valves. J Heart Valve Dis (2004) 2.02
Matrix metalloproteinase-13/collagenase-3 deletion promotes collagen accumulation and organization in mouse atherosclerotic plaques. Circulation (2005) 2.01
Early photon tomography allows fluorescence detection of lung carcinomas and disease progression in mice in vivo. Proc Natl Acad Sci U S A (2008) 2.00
Activatable magnetic resonance imaging agent reports myeloperoxidase activity in healing infarcts and noninvasively detects the antiinflammatory effects of atorvastatin on ischemia-reperfusion injury. Circulation (2008) 1.97
Chemokine CXCL10 promotes atherogenesis by modulating the local balance of effector and regulatory T cells. Circulation (2006) 1.95
Directed 3D cell alignment and elongation in microengineered hydrogels. Biomaterials (2010) 1.94
From stem cells to viable autologous semilunar heart valve. Circulation (2005) 1.94
Modular Tissue Engineering: Engineering Biological Tissues from the Bottom Up. Soft Matter (2009) 1.93
Tracking the inflammatory response in stroke in vivo by sensing the enzyme myeloperoxidase. Proc Natl Acad Sci U S A (2008) 1.91
Nano/Microfluidics for diagnosis of infectious diseases in developing countries. Adv Drug Deliv Rev (2009) 1.87
A simple soft lithographic route to fabrication of poly(ethylene glycol) microstructures for protein and cell patterning. Biomaterials (2004) 1.84
Human pulmonary valve progenitor cells exhibit endothelial/mesenchymal plasticity in response to vascular endothelial growth factor-A and transforming growth factor-beta2. Circ Res (2006) 1.80
Fabrication of gradient hydrogels using a microfluidics/photopolymerization process. Langmuir (2004) 1.76
Integrating microfluidics and lensless imaging for point-of-care testing. Biosens Bioelectron (2009) 1.74
Microfluidics for drug discovery and development: from target selection to product lifecycle management. Drug Discov Today (2007) 1.71
Selective matrix metalloproteinase inhibition reduces left ventricular remodeling but does not inhibit angiogenesis after myocardial infarction. Circulation (2002) 1.67
Microfabricated biomaterials for engineering 3D tissues. Adv Mater (2012) 1.65
Functional Human Vascular Network Generated in Photocrosslinkable Gelatin Methacrylate Hydrogels. Adv Funct Mater (2012) 1.63
Molecular imaging insights into early inflammatory stages of arterial and aortic valve calcification. Circ Res (2011) 1.62
Transglutaminase activity in acute infarcts predicts healing outcome and left ventricular remodelling: implications for FXIII therapy and antithrombin use in myocardial infarction. Eur Heart J (2008) 1.62
Controlling the porosity and microarchitecture of hydrogels for tissue engineering. Tissue Eng Part B Rev (2010) 1.61
Tissue-engineered microvessels on three-dimensional biodegradable scaffolds using human endothelial progenitor cells. Am J Physiol Heart Circ Physiol (2004) 1.59
Macrophage-derived matrix vesicles: an alternative novel mechanism for microcalcification in atherosclerotic plaques. Circ Res (2013) 1.58
Cell and protein compatibility of parylene-C surfaces. Langmuir (2007) 1.58
Stop-flow lithography to generate cell-laden microgel particles. Lab Chip (2008) 1.57
Micromolding of photocrosslinkable chitosan hydrogel for spheroid microarray and co-cultures. Biomaterials (2006) 1.54
Indocyanine green enables near-infrared fluorescence imaging of lipid-rich, inflamed atherosclerotic plaques. Sci Transl Med (2011) 1.54
Bioengineering challenges for heart valve tissue engineering. Annu Rev Biomed Eng (2009) 1.54
25th anniversary article: Rational design and applications of hydrogels in regenerative medicine. Adv Mater (2014) 1.52
Revised microcalcification hypothesis for fibrous cap rupture in human coronary arteries. Proc Natl Acad Sci U S A (2013) 1.51
Engineering microscale topographies to control the cell-substrate interface. Biomaterials (2012) 1.51
Controlled-size embryoid body formation in concave microwell arrays. Biomaterials (2010) 1.49
Cellular imaging of inflammation in atherosclerosis using magnetofluorescent nanomaterials. Mol Imaging (2006) 1.48
NFATc1 mediates vascular endothelial growth factor-induced proliferation of human pulmonary valve endothelial cells. J Biol Chem (2002) 1.46
Inhibition of bone morphogenetic protein signaling reduces vascular calcification and atherosclerosis. Arterioscler Thromb Vasc Biol (2012) 1.46
Layer by layer three-dimensional tissue epitaxy by cell-laden hydrogel droplets. Tissue Eng Part C Methods (2010) 1.46
Arterial and aortic valve calcification inversely correlates with osteoporotic bone remodelling: a role for inflammation. Eur Heart J (2010) 1.46
Carbon nanotube reinforced hybrid microgels as scaffold materials for cell encapsulation. ACS Nano (2011) 1.46
Cystathionine γ-lyase accelerates osteoclast differentiation: identification of a novel regulator of osteoclastogenesis by proteomic analysis. Arterioscler Thromb Vasc Biol (2013) 1.46
Perfusion improves tissue architecture of engineered cardiac muscle. Tissue Eng (2002) 1.46
Collagen fiber disruption occurs independent of calcification in clinically explanted bioprosthetic heart valves. J Biomed Mater Res (2002) 1.46
Microfluidic system for studying the interaction of nanoparticles and microparticles with cells. Anal Chem (2005) 1.45
Pulsatile distention of the nondiseased and stenotic aortic valve annulus: analysis with electrocardiogram-gated computed tomography. Ann Thorac Surg (2011) 1.44
Synthesis and characterization of tunable poly(ethylene glycol): gelatin methacrylate composite hydrogels. Tissue Eng Part A (2011) 1.44
Lipid lowering reduces oxidative stress and endothelial cell activation in rabbit atheroma. Circulation (2002) 1.43
Mechanically robust and bioadhesive collagen and photocrosslinkable hyaluronic acid semi-interpenetrating networks. Tissue Eng Part A (2009) 1.43
Fiber-based tissue engineering: Progress, challenges, and opportunities. Biotechnol Adv (2012) 1.42
Biomimetic tissues on a chip for drug discovery. Drug Discov Today (2011) 1.41
Simplified syntheses of complex multifunctional nanomaterials. Chem Commun (Camb) (2008) 1.41
Expression of connective tissue growth factor is increased in injured myocardium associated with protein kinase C beta2 activation and diabetes. Diabetes (2002) 1.39
Digitally tunable physicochemical coding of material composition and topography in continuous microfibres. Nat Mater (2011) 1.38
Cultivation of human embryonic stem cells without the embryoid body step enhances osteogenesis in vitro. Stem Cells (2005) 1.38
Micropatterned cell co-cultures using layer-by-layer deposition of extracellular matrix components. Biomaterials (2005) 1.38
In vivo detection of Staphylococcus aureus endocarditis by targeting pathogen-specific prothrombin activation. Nat Med (2011) 1.38
The independent role of cyclic flexure in the early in vitro development of an engineered heart valve tissue. Biomaterials (2005) 1.36
Molecular imaging of innate immune cell function in transplant rejection. Circulation (2009) 1.34
Microfabrication of complex porous tissue engineering scaffolds using 3D projection stereolithography. Biomaterials (2012) 1.34
Myeloperoxidase-targeted imaging of active inflammatory lesions in murine experimental autoimmune encephalomyelitis. Brain (2008) 1.34